Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

We need both natural and energy solutions to stabilize our climate.

Griscom BW, Lomax G, Kroeger T, Fargione JE, Adams J, Almond L, Bossio D, Cook-Patton SC, Ellis PW, Kennedy CM, Kiesecker J.

Glob Chang Biol. 2019 Jun;25(6):1889-1890. doi: 10.1111/gcb.14612. Epub 2019 Mar 22.

2.

Natural climate solutions for the United States.

Fargione JE, Bassett S, Boucher T, Bridgham SD, Conant RT, Cook-Patton SC, Ellis PW, Falcucci A, Fourqurean JW, Gopalakrishna T, Gu H, Henderson B, Hurteau MD, Kroeger KD, Kroeger T, Lark TJ, Leavitt SM, Lomax G, McDonald RI, Megonigal JP, Miteva DA, Richardson CJ, Sanderman J, Shoch D, Spawn SA, Veldman JW, Williams CA, Woodbury PB, Zganjar C, Baranski M, Elias P, Houghton RA, Landis E, McGlynn E, Schlesinger WH, Siikamaki JV, Sutton-Grier AE, Griscom BW.

Sci Adv. 2018 Nov 14;4(11):eaat1869. doi: 10.1126/sciadv.aat1869. eCollection 2018 Nov.

3.

CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges.

Jamieson CHM, Millan MT, Creasey AA, Lomax G, Donohoe ME, Walters MC, Abedi M, Bota DA, Zaia JA, Adams JS.

Cell Stem Cell. 2018 Jun 1;22(6):801-805. doi: 10.1016/j.stem.2018.05.007.

4.

A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells.

Kurtz A, Seltmann S, Bairoch A, Bittner MS, Bruce K, Capes-Davis A, Clarke L, Crook JM, Daheron L, Dewender J, Faulconbridge A, Fujibuchi W, Gutteridge A, Hei DJ, Kim YO, Kim JH, Kokocinski AK, Lekschas F, Lomax GP, Loring JF, Ludwig T, Mah N, Matsui T, Müller R, Parkinson H, Sheldon M, Smith K, Stachelscheid H, Stacey G, Streeter I, Veiga A, Xu RH.

Stem Cell Reports. 2018 Jan 9;10(1):1-6. doi: 10.1016/j.stemcr.2017.12.002. Review.

5.

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.

Illes J, Sipp D, Kleiderman E, Benjaminy S, Isasi R, Lomax G, Master Z, McCormick J, Ogbogu U, Ravitsky V, Robillard JM, Rossi F, Wilson B, Zarzeczny A.

NPJ Regen Med. 2017 Jul 5;2:21. doi: 10.1038/s41536-017-0026-z. eCollection 2017. Review.

6.

Role of Nursing Competencies for Accelerating Clinical Trials in Stem Cell Clinics.

Perrin M, Kim T, Stan R, Giesie P, Tabor J, Le Verche V, Johnson S, Lomax GP, Zaia JA.

Stem Cells Transl Med. 2018 Jan;7(1):6-10. doi: 10.1002/sctm.17-0165. Epub 2017 Nov 3.

7.

Natural climate solutions.

Griscom BW, Adams J, Ellis PW, Houghton RA, Lomax G, Miteva DA, Schlesinger WH, Shoch D, Siikamäki JV, Smith P, Woodbury P, Zganjar C, Blackman A, Campari J, Conant RT, Delgado C, Elias P, Gopalakrishna T, Hamsik MR, Herrero M, Kiesecker J, Landis E, Laestadius L, Leavitt SM, Minnemeyer S, Polasky S, Potapov P, Putz FE, Sanderman J, Silvius M, Wollenberg E, Fargione J.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):11645-11650. doi: 10.1073/pnas.1710465114. Epub 2017 Oct 16. Erratum in: Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2776.

8.

Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.

Kim JH, Kurtz A, Yuan BZ, Zeng F, Lomax G, Loring JF, Crook J, Ju JH, Clarke L, Inamdar MS, Pera M, Firpo MT, Sheldon M, Rahman N, O'Shea O, Pranke P, Zhou Q, Isasi R, Rungsiwiwut R, Kawamata S, Oh S, Ludwig T, Masui T, Novak TJ, Takahashi T, Fujibuchi W, Koo SK, Stacey GN.

Stem Cells Transl Med. 2017 Nov;6(11):1956-1962. doi: 10.1002/sctm.17-0144. Epub 2017 Oct 24.

9.

An upper and lower bound of the Medication Possession Ratio.

Sperber CM, Samarasinghe SR, Lomax GP.

Patient Prefer Adherence. 2017 Aug 30;11:1469-1478. doi: 10.2147/PPA.S136890. eCollection 2017.

10.

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q.

Regen Med. 2015;10(2 Suppl):1-44. doi: 10.2217/rme.14.93. No abstract available.

PMID:
25675265
11.

The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens.

Lomax GP, Hull SC, Isasi R.

Stem Cells Transl Med. 2015 Feb;4(2):123-9. doi: 10.5966/sctm.2014-0192. Epub 2015 Jan 5. Review.

12.

Research ethics and stem cells: Is it time to re-think current approaches to oversight?

Caulfield T, Kamenova K, Ogbogu U, Zarzeczny A, Baltz J, Benjaminy S, Cassar PA, Clark M, Isasi R, Knoppers B, Knowles L, Korbutt G, Lavery JV, Lomax GP, Master Z, McDonald M, Preto N, Toews M.

EMBO Rep. 2015 Jan;16(1):2-6. doi: 10.15252/embr.201439819. Epub 2014 Dec 4. No abstract available.

13.

Pharmaceutical industry interactions of psychiatric trainees from 20 European countries.

Riese F, Guloksuz S, Roventa C, Fair JD, Haravuori H, Rolko T, Flynn D, Giacco D, Banjac V, Jovanovic N, Bayat N, Palumbo C, Rusaka M, Kilic O, Augėnaitė J, Nawka A, Zenger M, Kekin I, Wuyts P, Barrett E, Bausch-Becker N, Mikaliūnas J, Del Valle E, Feffer K, Lomax GA, Marques JG, Jauhar S.

Eur Psychiatry. 2015 Feb;30(2):284-90. doi: 10.1016/j.eurpsy.2014.09.417. Epub 2014 Nov 20.

PMID:
25456156
14.

Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Canet-Aviles R, Lomax GP, Feigal EG, Priest C.

Stem Cells Transl Med. 2014 Sep;3(9):979-91. doi: 10.5966/sctm.2014-0146. Epub 2014 Aug 22.

15.

How California Institute for Regenerative Medicine research programs support science and regulatory policy.

Lomax GP, DeWitt ND, Millan MT, Feigal EG.

Stem Cells Transl Med. 2014 Jun;3(6):673-4. doi: 10.5966/sctm.2014-0069. Epub 2014 Apr 25. No abstract available.

16.

Identifiability and privacy in pluripotent stem cell research.

Isasi R, Andrews PW, Baltz JM, Bredenoord AL, Burton P, Chiu IM, Hull SC, Jung JW, Kurtz A, Lomax G, Ludwig T, McDonald M, Morris C, Ng HH, Rooke H, Sharma A, Stacey GN, Williams C, Zeng F, Knoppers BM.

Cell Stem Cell. 2014 Apr 3;14(4):427-30. doi: 10.1016/j.stem.2014.03.014.

17.

Somatic cell nuclear transfer in Oregon: expanding the pluripotent space and informing research ethics.

Lomax GP, DeWitt ND.

Stem Cells Dev. 2013 Dec;22 Suppl 1:25-8. doi: 10.1089/scd.2013.0402.

PMID:
24304071
18.

The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Lomax GP, Hull SC, Lowenthal J, Rao M, Isasi R.

Stem Cells Transl Med. 2013 Oct;2(10):727-30. doi: 10.5966/sctm.2013-0099. Epub 2013 Aug 29.

19.

Correcting misperceptions about cryopreserved embryos and stem cell research.

Lomax GP, Trounson AO.

Nat Biotechnol. 2013 Apr;31(4):288-90. doi: 10.1038/nbt.2541. No abstract available.

PMID:
23563418
20.

Return of results in translational iPS cell research: considerations for donor informed consent.

Lomax GP, Shepard KA.

Stem Cell Res Ther. 2013 Jan 21;4(1):6. doi: 10.1186/scrt154. Review.

21.

The great ESCRO experiment: there is still value to be gained.

Lomax G.

Am J Bioeth. 2013;13(1):55-6. doi: 10.1080/15265161.2012.747034. No abstract available.

PMID:
23311847
22.

Broad consent in biobanking.

Hempel C, Lomax G, Peckman S.

Nat Biotechnol. 2012 Sep;30(9):826. doi: 10.1038/nbt.2349. No abstract available.

PMID:
22965048
23.

Disclosure and management of research findings in stem cell research and banking: policy statement.

Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F; International Stem Cell Forum Ethics Working Party.

Regen Med. 2012 May;7(3):439-48. doi: 10.2217/rme.12.23.

PMID:
22594334
24.

Do psychiatric inpatients know their rights? A re-audit on information given to inpatients at a London mental health trust about their rights and admission to hospital.

Lomax GA, Raphael F, Pagliero J, Patel R.

Med Sci Law. 2012 Jan;52(1):36-9. doi: 10.1258/msl.2011.011075. Epub 2011 Nov 30.

PMID:
22399028
25.

Sustained interaction: the new normal for stem cell repositories?

Isasi R, Knoppers BM, Lomax G.

Regen Med. 2011 Nov;6(6):783-92. doi: 10.2217/rme.11.93. Review.

PMID:
22050529
26.

Social media & stem cell science: examining the discourse.

Adams A, Lomax G, Santarini A.

Regen Med. 2011 Nov;6(6 Suppl):121-4. doi: 10.2217/rme.11.82.

27.

Stem cell policy exceptionalism: proceed with caution.

Lomax GP, Peckman SR.

Stem Cell Rev. 2012 Jun;8(2):299-304. doi: 10.1007/s12015-011-9305-z.

PMID:
21837381
28.

Clinical trials for stem cell therapies.

Trounson A, Thakar RG, Lomax G, Gibbons D.

BMC Med. 2011 May 10;9:52. doi: 10.1186/1741-7015-9-52. Review.

29.

A call for standardized naming and reporting of human ESC and iPSC lines.

Luong MX, Auerbach J, Crook JM, Daheron L, Hei D, Lomax G, Loring JF, Ludwig T, Schlaeger TM, Smith KP, Stacey G, Xu RH, Zeng F.

Cell Stem Cell. 2011 Apr 8;8(4):357-9. doi: 10.1016/j.stem.2011.03.002.

30.

Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party.

Knoppers BM, Isasi R, Benvenisty N, Kim OJ, Lomax G, Morris C, Murray TH, Lee EH, Perry M, Richardson G, Sipp D, Tanner K, Wahlström J, de Wert G, Zeng F.

Stem Cell Rev. 2011 Sep;7(3):482-4. doi: 10.1007/s12015-010-9226-2.

31.

Proposed oocyte donation guidelines for stem cell research.

Carson SA, Eschenbach DA, Lomax G, Rice VM, Sauer MV, Taylor RN; California Institute of Regenerative Medecine advisory committee.

Fertil Steril. 2010 Dec;94(7):2503-6. doi: 10.1016/j.fertnstert.2009.12.062. Epub 2010 Mar 1.

PMID:
20189168
32.

The stem cell research environment: a patchwork of patchworks.

Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Premji S, von Tigerstrom B, Winickoff DE.

Stem Cell Rev. 2009 Jun;5(2):82-8. doi: 10.1007/s12015-009-9071-3. Epub 2009 May 27. Review.

PMID:
19521798
33.

Harmonizing standards and coding for hESC research.

Lomax G, McNab A.

Cell Stem Cell. 2008 Mar 6;2(3):201-2. doi: 10.1016/j.stem.2008.02.002. Review. No abstract available.

34.
35.
36.

Can half-day trainings motivate small contractors to address lead safety?

Harrington D, Scholz P, Lomax G, Stahlschmidt H, Vannoy J, Materna B.

Health Promot Pract. 2004 Jul;5(3):297-305.

PMID:
15228785
37.

Assessment of the scientific basis for genetic testing of railroad workers with carpal tunnel syndrome.

Schulte PA, Lomax G.

J Occup Environ Med. 2003 Jun;45(6):592-600. Review.

PMID:
12802212
38.

Chevron v. Echazabal: a sobering decision for environmental health research.

Lomax G.

Environ Health Perspect. 2002 Sep;110(9):A504-5. No abstract available.

39.

Ministry of health brands article 'misleading'.

Lomax G.

Nurs N Z. 2000 Nov;6(10):4; author reply 4. No abstract available.

PMID:
12012490
40.

Results of an intervention to improve lead safety among painting contractors and their employees.

Materna BL, Harrington D, Scholz P, Payne SF, Stubbs HA, Hipkins K, Merideth E, Kirsch L, Lomax G, Coyle P, Uratsu C.

Am J Ind Med. 2002 Feb;41(2):119-30.

PMID:
11813217
41.

Online patient information.

Lomax G, Barker Z.

J Telemed Telecare. 2001;7(4):244-6. No abstract available.

PMID:
11506761
42.

From breeder reactors to butterflies: risk, culture, and biotechnology.

Lomax GP.

Risk Anal. 2000 Oct;20(5):747-53.

PMID:
11110220
43.

Ethical issues in the use of genetic markers in occupational epidemiologic research.

Schulte PA, Lomax GP, Ward EM, Colligan MJ.

J Occup Environ Med. 1999 Aug;41(8):639-46. Review.

PMID:
10457506
44.

A cost-benefit analysis of genetic screening for susceptibility to occupational toxicants.

Nicas M, Lomax GP.

J Occup Environ Med. 1999 Jul;41(7):535-44.

PMID:
10412095
45.

The determination of protein-bound salicylates.

Lomax GD.

J Med Lab Technol. 1970 Jan;27(1):61-71. No abstract available.

PMID:
5412557
46.

Hypermagnesaemia and platelet function in uraemic bleeding.

Davies DT, Hughes A, Lomax GD, Tonks RS.

Lancet. 1968 Feb 10;1(7537):301-2. No abstract available.

PMID:
4170756
47.

Determination of protein-bound magnesium and calcium by gel filtration.

Lomax GD.

J Med Lab Technol. 1967 Apr;24(2):103-12. No abstract available.

PMID:
6042100
48.

Some pathogenic agents found in hippopotamus in Uganda.

GUILBRIDE PD, COYLE TJ, McANULTY EG, BARBER L, LOMAX GD.

J Comp Pathol. 1962 Apr;72:137-41. No abstract available.

PMID:
13902797
49.

Paper electrophoresis of hippopotamus haemoglobin.

ROLLINSON DH, LOMAX GD.

Nature. 1959 Nov 21;184(Suppl 21):1653-4. No abstract available.

PMID:
14438536
50.

The use of Nile blue in the enumeration and cytological examination of cells in fluid medium.

LOMAX GD.

J Med Lab Technol. 1957 Apr;14(2):107. No abstract available.

PMID:
13463535

Supplemental Content

Support Center